Gentiopicroside Attenuates Renal Ischemia-Reperfusion Injury through Suppression of JNK/MAPK Signaling.

Luo L, Liu J, Zhang N, Meng W, Liu Y

Open source

DOI
10.1016/j.ejphar.2026.179356
Published
2026 Sep 23
Container
European journal of pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179356,
  title = {Gentiopicroside Attenuates Renal Ischemia-Reperfusion Injury through Suppression of JNK/MAPK Signaling.},
  author = {Luo L and Liu J and Zhang N and Meng W and Liu Y},
  year = {2026},
  journal = {European journal of pharmacology},
  doi = {10.1016/j.ejphar.2026.179356},
  url = {https://doi.org/10.1016/j.ejphar.2026.179356}
}

RIS

TY  - JOUR
TI  - Gentiopicroside Attenuates Renal Ischemia-Reperfusion Injury through Suppression of JNK/MAPK Signaling.
AU  - Luo L
AU  - Liu J
AU  - Zhang N
AU  - Meng W
AU  - Liu Y
PY  - 2026
JO  - European journal of pharmacology
DO  - 10.1016/j.ejphar.2026.179356
UR  - https://doi.org/10.1016/j.ejphar.2026.179356
ER  - 

APA

L, L., J, L., N, Z., W, M., & Y, L. (2026). Gentiopicroside Attenuates Renal Ischemia-Reperfusion Injury through Suppression of JNK/MAPK Signaling.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179356

Source records